logo
Suzlon Energy share price climbs 3% after securing 170.1 MW wind power project

Suzlon Energy share price climbs 3% after securing 170.1 MW wind power project

Mint20-06-2025
Suzlon Energy share price in focus: Shares of Suzlon Energy, one of the leading global renewable energy solutions providers, rose nearly 3% in intraday trade on Friday, June 20, hitting a high of ₹ 64.26 apiece and ending a three-day losing streak after the company announced a new 170.1 MW project win.
In an exchange filing today, the company stated that it had received its third successive order from AMPIN for a 170.1 MW wind power project to be developed in Kurnool, Andhra Pradesh.
As part of the contract, Suzlon will supply 54 of its advanced S144 wind turbine generators (WTGs) with Hybrid Lattice Towers (HLT), each with a rated capacity of 3.15 MW. The scope of the project includes complete execution—from equipment supply and installation to commissioning and long-term operations and maintenance services.
JP Chalasani, Chief Executive Officer of the Suzlon Group, said, 'India's decarbonization journey will be won or lost at the distribution level. DISCOMs are the critical link between renewable energy generation and everyday consumption—from industries to households. To empower them with reliable, cost-efficient clean power is not just a goal—it's a national imperative. Together, we're proving that clean energy isn't just viable—it's vital, scalable, and transformative for the power sector.'
Suzlon achieved a record quarterly delivery of 573 MW in Q4 FY25, bringing total deliveries in FY25 to 1.55 GW. The company's order book reached an all-time high of 5.6 GW, with the S144 platform alone surpassing 5 GW, solidifying its position as a market leader in India.
The company also added 10 new production lines for its S144–3.X MW series and completed nacelle expansions at its Daman and Pondicherry facilities. Suzlon further announced plans to continue investing in a robust local manufacturing and supply chain ecosystem to support India's wind energy goals.
Despite the positive momentum, Suzlon shares have been under pressure since touching a 52-week high of ₹ 74.30 on May 30, as investors opted to book profits following the strong rally driven by robust March quarter and FY25 performance, along with steady order wins.
Between May 9 and May 30, the stock surged from ₹ 52.60 to ₹ 71.50, delivering an impressive 36% gain in just 16 trading sessions. For FY25, Suzlon Energy's net profit jumped to ₹ 2,072 crore from ₹ 660 crore in FY24, driven by a ₹ 10,851 crore rise in revenue.
The WTG business accounted for 78% of FY25 revenue, while the remainder came from the OMS (Operations and Maintenance Services) business. Suzlon's net cash position improved to ₹ 1,943 crore as of March 2025, up ₹ 836 crore compared to December 2024.
Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before taking any investment decisions.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Serentica Renewables to procure wind turbines from SANY Renewable for 336 MW Karnataka project
Serentica Renewables to procure wind turbines from SANY Renewable for 336 MW Karnataka project

Time of India

time13 hours ago

  • Time of India

Serentica Renewables to procure wind turbines from SANY Renewable for 336 MW Karnataka project

Renewable energy firm Serentica Renewables on Tuesday said it will procure Wind Turbine Generators for its 336 MW Wind Project in Karnataka from SANY Renewable . Delivery for the project is expected to commence by December 2025, a company statement said. Explore courses from Top Institutes in Please select course: Select a Course Category Healthcare Digital Marketing CXO Finance Operations Management others Design Thinking Management MBA MCA Project Management Data Analytics Degree Product Management healthcare Leadership Data Science Technology PGDM Cybersecurity Others Public Policy Data Science Artificial Intelligence Skills you'll gain: Financial Analysis in Healthcare Financial Management & Investing Strategic Management in Healthcare Process Design & Analysis Duration: 12 Weeks Indian School of Business Certificate Program in Healthcare Management Starts on Jun 13, 2024 Get Details Serentica Renewables has selected SANY Renewable, a leading enterprise of high-end equipment manufacturing, to supply the Wind Turbine Generators (WTGs) for its 336 MW Wind Project in Karnataka, according to the statement by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 15 most beautiful women in the world Undo The project will feature advanced SANY WTGs, each with a rated capacity of 4 MW. Akshay Hiranandani, CEO, Serentica Renewables, said in the statement, "336 MW wind project in Karnataka will play a pivotal role in reducing carbon emissions while providing a reliable, renewable energy source to industrial consumers." Live Events Gaurav Amdekar, COO, SANY Wind Energy India, said, "This partnership demonstrates our shared commitment to driving the transition to a low-carbon economy and contributing to India's renewable energy targets." Serentica shortlisted SANY Renewable's high-performance wind turbines for their superior reliability, efficiency, and capacity to deliver sustained power. These turbines will play a pivotal role in generating sustainable power for energy-intensive industries. Established in 2022, Serentica Renewables is a leading renewable Independent Power Producer committed to decarbonising hard-to-abate industries by providing firm dispatchable renewable energy solutions.

Mutual funds boost holding in Suzlon Energy to an all-time high in June quarter
Mutual funds boost holding in Suzlon Energy to an all-time high in June quarter

Mint

time2 days ago

  • Mint

Mutual funds boost holding in Suzlon Energy to an all-time high in June quarter

Mutual funds increased their bets on Suzlon Energy in the June quarter, as the latest shareholding data reveals that domestic fund houses collectively picked up an additional 1.07% stake in the wind energy company during the period. As of the end of June 2025, 30 mutual funds collectively held a 5.24% stake in Suzlon Energy, equivalent to 7.18 crore shares. This marks a notable increase from 4.17% at the end of the March quarter and 3.82% in Q1FY25, according to BSE shareholding data. The data also shows that Motilal Oswal Midcap Fund now holds a 1.03% stake in the company—a new addition, as the fund had no holdings in Suzlon at the end of March. Meanwhile, the Life Insurance Corporation of India (LIC) continues to hold a 1.02% stake. Retail investors also slightly increased their holdings by 0.1% to 55.1%, while promoters trimmed their stake to 11.7% from 13.3% in Q1FY25. Suzlon has remained on investors' radar in recent months due to positive brokerage views and multiple orders. Motilal Oswal, for instance, recently issued a 'buy' rating with a target price of ₹ 82 per share. The brokerage's optimism is driven by the expected adoption of the Revised List of Models and Manufacturers (RLMM) local content draft notification by Q2FY26, strong order prospects, the gradual phase-out of the ISTS waiver over the next four years, and an increasing share of EPC projects in the order book. Discussions with industry participants suggest that the RLMM notification—mandating local content in key wind turbine components—is likely to be formally implemented in Q2FY26. Motilal Oswal believes that Suzlon is well-positioned to benefit from favorable regulatory developments, a growing order book offering strong revenue visibility, and operational gains through proactive land acquisition and EPC expansion. Earlier, Anand Rathi also noted that Suzlon's 5.6 GW order book, which is 3.6x its FY25 execution volume, provides long-term growth visibility and ensures a steady pipeline of projects. It also reinitiated coverage with a 'buy' rating and a target price of ₹ 81 apiece. Despite these positive projections, the stock has come under pressure in recent months due to broader market weakness, declining 12% from its recent highs. However, Suzlon remains a strong long-term performer, with shares rising 277% over the past two years and over 1,200% in the last five years. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before taking any investment decisions.

Top stocks to buy: Stock recommendations for the week starting July 14, 2025
Top stocks to buy: Stock recommendations for the week starting July 14, 2025

Time of India

time14-07-2025

  • Time of India

Top stocks to buy: Stock recommendations for the week starting July 14, 2025

Top stocks to buy (AI image) Stock market recommendations: According to Motilal Oswal Financial Services Ltd, the top stock picks for the week (starting July 14, 2025) are Suzlon, and Glenmark Pharma. Let's take a look: Stock Name CMP (Rs) Target (Rs) Upside (%) Suzlon 66 82 24% Glenmark 2175 2430 12% Suzlon Suzlon new order outlook remains healthy with expected order inflow of ~4GW in FY26, including potential ~1.5GW NTPC orders, which implies total potential OB of ~6.5GW by FY26 end. EPC share is likely to rise from 20% now to ~50% in the medium term, improving execution visibility. Revised list of Models & Manufacturers (RLMM) mandating local content for key components in wind turbines is likely to be formally adopted in 2QFY26. Gradual Inter-state transmission system (ISTS) waiver phase-out will support smoother project execution. Suzlon stands to benefit from proactive land acquisition and EPC expansion initiatives. Cash conversion cycle is expected to improve by 30-35 days which will enhance balance sheet strength & generate higher free cash flow, supporting sustainable RoEs. Glenmark Pharma Glenmark's subsidiary Ichnos Glenmark Innovation (IGI) has signed an exclusive licensing agreement with AbbVie, a diversified biopharma leader, for its oncology product ISB-2001, validating clinical & commercial potential of IGI's BEAT® protein platform. The $700m upfront—world's 4th largest payment—along with $1.2b in milestones, boosts R&D monetization. Tiered double-digit royalties offer annuity income, while ANDA pipeline expansion & domestic reset further support growth. AbbVie will commercialize ISB-2001 in developed markets, while Glenmark retains rights in emerging markets. Improved leverage and a domestic reset underpin 11%/17%/20% sales/EBITDA/PAT CAGR over FY25-27. We add INR470/share NPV to arrive at a TP of INR2,430, supported by its pivot toward innovation-led growth. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store